Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT05242471




Registration number
NCT05242471
Ethics application status
Date submitted
15/02/2022
Date registered
16/02/2022
Date last updated
31/10/2024

Titles & IDs
Public title
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Scientific title
A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Secondary ID [1] 0 0
2021-003314-39
Secondary ID [2] 0 0
CR109178
Universal Trial Number (UTN)
Trial acronym
DUET-CD
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Crohn's Disease 0 0
Condition category
Condition code
Oral and Gastrointestinal 0 0 0 0
Inflammatory bowel disease
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders
Oral and Gastrointestinal 0 0 0 0
Crohn's disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Other - Guselkumab
Treatment: Other - Golimumab
Treatment: Other - JNJ-78934804
Treatment: Drugs - Placebo

Placebo comparator: Group 1: Placebo - Participants will receive placebo subcutaneously (SC). All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 2: Guselkumab - Participants will receive guselkumab dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 3: Golimumab - Participants will receive golimumab dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 4: JNJ-78934804 (High-dose) - Participants will receive JNJ-78934804 dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 5: JNJ-78934804 (Mid-dose) - Participants will receive JNJ-78934804 dose regimen 2 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Experimental: Group 6: JNJ-78934804 (Low-dose) - Participants will receive JNJ-78934804 dose regimen 3 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.


Treatment: Other: Guselkumab
Guselkumab will be administered as subcutaneous injection.

Treatment: Other: Golimumab
Golimumab will be administered as subcutaneous injection.

Treatment: Other: JNJ-78934804
JNJ-78934804 will be administered subcutaneously as per defined regimen.

Treatment: Drugs: Placebo
Placebo will be administered as subcutaneous injection.
Intervention code [1] 0 0
Treatment: Other
Intervention code [2] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Percentage of Participants with Clinical Remission at Week 48
Timepoint [1] 0 0
Week 48
Primary outcome [2] 0 0
Percentage of Participants with Endoscopic Response at Week 48
Timepoint [2] 0 0
Week 48
Secondary outcome [1] 0 0
Percentage of Participants with Patient-reported Outcomes (PRO)-2 Remission at Week 48
Timepoint [1] 0 0
Week 48
Secondary outcome [2] 0 0
Percentage of Participants with Endoscopic Remission at Week 48
Timepoint [2] 0 0
Week 48
Secondary outcome [3] 0 0
Percentage of Participants with Corticosteroid-Free Clinical Remission at Week 48
Timepoint [3] 0 0
Week 48
Secondary outcome [4] 0 0
Secondary Comparison: Percentage of Participants with Clinical Remission at Week 48
Timepoint [4] 0 0
Week 48
Secondary outcome [5] 0 0
Secondary Comparison: Percentage of Participants with Endoscopic Response at Week 48
Timepoint [5] 0 0
Week 48
Secondary outcome [6] 0 0
Percentage of Participants with Adverse Events (AEs)
Timepoint [6] 0 0
Up to Week 48
Secondary outcome [7] 0 0
Percentage of Participants with Serious Adverse Events (SAEs)
Timepoint [7] 0 0
Up to Week 48
Secondary outcome [8] 0 0
Clinical Laboratory Parameters Over Time
Timepoint [8] 0 0
Up to Week 48
Secondary outcome [9] 0 0
Vital Sign Parameters Over Time
Timepoint [9] 0 0
Up to Week 48
Secondary outcome [10] 0 0
Suicidal Ideation Assessment Using Columbia Suicide Severity Rating Scale (C-SSRS) Score
Timepoint [10] 0 0
Up to Week 48
Secondary outcome [11] 0 0
Serum Concentrations of Guselkumab Over Time
Timepoint [11] 0 0
Up to Week 48
Secondary outcome [12] 0 0
Serum Concentrations of Golimumab Over Time
Timepoint [12] 0 0
Up to Week 48
Secondary outcome [13] 0 0
Percentage of Participants with Antibodies to Guselkumab
Timepoint [13] 0 0
Up to Week 48
Secondary outcome [14] 0 0
Titers of Antibodies to Guselkumab
Timepoint [14] 0 0
Up to Week 48
Secondary outcome [15] 0 0
Percentage of Participants with Antibodies to Golimumab
Timepoint [15] 0 0
Up to Week 48
Secondary outcome [16] 0 0
Titers of Antibodies to Golimumab
Timepoint [16] 0 0
Up to Week 48
Secondary outcome [17] 0 0
Percentage of Participants with Neutralizing Antibodies to Guselkumab.
Timepoint [17] 0 0
Up to Week 48
Secondary outcome [18] 0 0
Percentage of Participants with Neutralizing Antibodies to Golimumab
Timepoint [18] 0 0
Up to Week 48

Eligibility
Key inclusion criteria
* Diagnosis of Crohn's disease (CD) for at least 3 months prior to baseline
* Confirmed diagnosis of moderate to severe CD as assessed by Crohn's disease activity index (CDAI), stool frequency (SF), abdominal pain (AP) score and simple endoscopic score for Crohn's disease (SES-CD)
* Demonstrated inadequate response, loss of response, or intolerance to at least one biologic approved for the treatment of Crohn's disease
* If female and of childbearing potential, must meet the contraception and reproduction requirements
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Complications of CD that may be anticipated to require surgery
* Currently has or is suspected to have an abscess. Recent cutaneous and perianal abscesses are not exclusionary if drained and adequately treated at least 3 weeks before baseline, or 8 weeks before baseline for intra-abdominal abscesses, provided that there is no anticipated need for any further surgery
* Has had any kind of bowel resection within 24 weeks, or any other intra-abdominal or other major surgery within 12 weeks
* Has a draining (example, functioning) stoma or ostomy
* Currently has a malignancy or has a history of malignancy within 5 years before screening (with the exception of a nonmelanoma skin cancer or cervical carcinoma in situ that has been adequately treated with no evidence of recurrence for greater than or equal do (>=) 12 months before the first dose of study intervention)
* Has a history of, or ongoing, chronic or recurrent infectious disease, including but not limited to, sinopulmonary infections, bronchiectasis, recurrent renal/urinary tract infections (example, pyelonephritis, cystitis), an open, draining, or infected skin wound, or an ulcer

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 2
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
22/07/2022
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
5/11/2029
Actual
Sample size
Target
Accrual to date
Final
703
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
The Queen Elizabeth Hospital - Adelaide
Recruitment hospital [2] 0 0
Box Hill Hospital - Box Hill
Recruitment hospital [3] 0 0
Monash Health, Monash Medical Centre - Clayton
Recruitment hospital [4] 0 0
Western Health - Footscray
Recruitment hospital [5] 0 0
St Vincent's hospital - Melbourne
Recruitment hospital [6] 0 0
Royal Prince Alfred Hospital - Newtown
Recruitment hospital [7] 0 0
Royal Adelaide Hospital - North Terrace
Recruitment hospital [8] 0 0
Royal Melbourne Hospital - Parkville
Recruitment hospital [9] 0 0
Nepean Hospital - Penrith
Recruitment hospital [10] 0 0
Mater Hospital Brisbane Inflammatory Bowel Diseases - South Brisbane
Recruitment postcode(s) [1] 0 0
5011 - Adelaide
Recruitment postcode(s) [2] 0 0
3128 - Box Hill
Recruitment postcode(s) [3] 0 0
3168 - Clayton
Recruitment postcode(s) [4] 0 0
3011 - Footscray
Recruitment postcode(s) [5] 0 0
3002 - Melbourne
Recruitment postcode(s) [6] 0 0
2042 - Newtown
Recruitment postcode(s) [7] 0 0
5000 - North Terrace
Recruitment postcode(s) [8] 0 0
3050 - Parkville
Recruitment postcode(s) [9] 0 0
2747 - Penrith
Recruitment postcode(s) [10] 0 0
4101 - South Brisbane
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
Arkansas
Country [4] 0 0
United States of America
State/province [4] 0 0
California
Country [5] 0 0
United States of America
State/province [5] 0 0
Colorado
Country [6] 0 0
United States of America
State/province [6] 0 0
Connecticut
Country [7] 0 0
United States of America
State/province [7] 0 0
District of Columbia
Country [8] 0 0
United States of America
State/province [8] 0 0
Florida
Country [9] 0 0
United States of America
State/province [9] 0 0
Georgia
Country [10] 0 0
United States of America
State/province [10] 0 0
Illinois
Country [11] 0 0
United States of America
State/province [11] 0 0
Indiana
Country [12] 0 0
United States of America
State/province [12] 0 0
Kansas
Country [13] 0 0
United States of America
State/province [13] 0 0
Kentucky
Country [14] 0 0
United States of America
State/province [14] 0 0
Louisiana
Country [15] 0 0
United States of America
State/province [15] 0 0
Maryland
Country [16] 0 0
United States of America
State/province [16] 0 0
Massachusetts
Country [17] 0 0
United States of America
State/province [17] 0 0
Michigan
Country [18] 0 0
United States of America
State/province [18] 0 0
Mississippi
Country [19] 0 0
United States of America
State/province [19] 0 0
Missouri
Country [20] 0 0
United States of America
State/province [20] 0 0
Nevada
Country [21] 0 0
United States of America
State/province [21] 0 0
New Hampshire
Country [22] 0 0
United States of America
State/province [22] 0 0
New York
Country [23] 0 0
United States of America
State/province [23] 0 0
North Carolina
Country [24] 0 0
United States of America
State/province [24] 0 0
Ohio
Country [25] 0 0
United States of America
State/province [25] 0 0
Oregon
Country [26] 0 0
United States of America
State/province [26] 0 0
Pennsylvania
Country [27] 0 0
United States of America
State/province [27] 0 0
South Carolina
Country [28] 0 0
United States of America
State/province [28] 0 0
Tennessee
Country [29] 0 0
United States of America
State/province [29] 0 0
Texas
Country [30] 0 0
United States of America
State/province [30] 0 0
Utah
Country [31] 0 0
United States of America
State/province [31] 0 0
Virginia
Country [32] 0 0
United States of America
State/province [32] 0 0
Washington
Country [33] 0 0
United States of America
State/province [33] 0 0
West Virginia
Country [34] 0 0
Austria
State/province [34] 0 0
Salzburg
Country [35] 0 0
Austria
State/province [35] 0 0
Vienna
Country [36] 0 0
Austria
State/province [36] 0 0
Wels
Country [37] 0 0
Austria
State/province [37] 0 0
Wien
Country [38] 0 0
Belgium
State/province [38] 0 0
Antwerpen
Country [39] 0 0
Belgium
State/province [39] 0 0
Brugge
Country [40] 0 0
Belgium
State/province [40] 0 0
Bruxelles
Country [41] 0 0
Belgium
State/province [41] 0 0
Gent
Country [42] 0 0
Belgium
State/province [42] 0 0
Leuven
Country [43] 0 0
Belgium
State/province [43] 0 0
Liege
Country [44] 0 0
Belgium
State/province [44] 0 0
Liège
Country [45] 0 0
Belgium
State/province [45] 0 0
Mechelen
Country [46] 0 0
Belgium
State/province [46] 0 0
Roeselare
Country [47] 0 0
Belgium
State/province [47] 0 0
Sint-Niklaas
Country [48] 0 0
Brazil
State/province [48] 0 0
Belo Horizonte - MG
Country [49] 0 0
Brazil
State/province [49] 0 0
Botucatu
Country [50] 0 0
Brazil
State/province [50] 0 0
Brasilia
Country [51] 0 0
Brazil
State/province [51] 0 0
Curitiba
Country [52] 0 0
Brazil
State/province [52] 0 0
Jau
Country [53] 0 0
Brazil
State/province [53] 0 0
Natal
Country [54] 0 0
Brazil
State/province [54] 0 0
Porto Alegre
Country [55] 0 0
Brazil
State/province [55] 0 0
Ribeirao Preto
Country [56] 0 0
Brazil
State/province [56] 0 0
Rio de Janeiro
Country [57] 0 0
Brazil
State/province [57] 0 0
Santo Andre
Country [58] 0 0
Brazil
State/province [58] 0 0
Santos
Country [59] 0 0
Brazil
State/province [59] 0 0
Sao Paulo
Country [60] 0 0
Brazil
State/province [60] 0 0
São José Do Rio Preto
Country [61] 0 0
Brazil
State/province [61] 0 0
São Paulo
Country [62] 0 0
Bulgaria
State/province [62] 0 0
Sofia
Country [63] 0 0
Canada
State/province [63] 0 0
Alberta
Country [64] 0 0
Canada
State/province [64] 0 0
British Columbia
Country [65] 0 0
Canada
State/province [65] 0 0
Manitoba
Country [66] 0 0
Canada
State/province [66] 0 0
Nova Scotia
Country [67] 0 0
Canada
State/province [67] 0 0
Ontario
Country [68] 0 0
Canada
State/province [68] 0 0
Quebec
Country [69] 0 0
Canada
State/province [69] 0 0
Saskatchewan
Country [70] 0 0
Canada
State/province [70] 0 0
Bridgewater
Country [71] 0 0
Canada
State/province [71] 0 0
Saguenay
Country [72] 0 0
China
State/province [72] 0 0
Beijing
Country [73] 0 0
China
State/province [73] 0 0
Changsha
Country [74] 0 0
China
State/province [74] 0 0
Changzhou City
Country [75] 0 0
China
State/province [75] 0 0
Chengdu
Country [76] 0 0
China
State/province [76] 0 0
Chongqing
Country [77] 0 0
China
State/province [77] 0 0
Foshan
Country [78] 0 0
China
State/province [78] 0 0
Guangzhou
Country [79] 0 0
China
State/province [79] 0 0
Haikou
Country [80] 0 0
China
State/province [80] 0 0
Hangzhou
Country [81] 0 0
China
State/province [81] 0 0
Jinhua
Country [82] 0 0
China
State/province [82] 0 0
Nanchang
Country [83] 0 0
China
State/province [83] 0 0
Nanjing
Country [84] 0 0
China
State/province [84] 0 0
Shanghai
Country [85] 0 0
China
State/province [85] 0 0
Wuhan
Country [86] 0 0
China
State/province [86] 0 0
Wuxi
Country [87] 0 0
China
State/province [87] 0 0
Xiamen
Country [88] 0 0
China
State/province [88] 0 0
Yangzhou
Country [89] 0 0
China
State/province [89] 0 0
ZhuZhou
Country [90] 0 0
Croatia
State/province [90] 0 0
Bjelovar
Country [91] 0 0
Croatia
State/province [91] 0 0
Split
Country [92] 0 0
Croatia
State/province [92] 0 0
Zagreb
Country [93] 0 0
Czechia
State/province [93] 0 0
Brno
Country [94] 0 0
Czechia
State/province [94] 0 0
Praha 9
Country [95] 0 0
Czechia
State/province [95] 0 0
Usti nad Labem
Country [96] 0 0
Denmark
State/province [96] 0 0
Aarhus
Country [97] 0 0
Denmark
State/province [97] 0 0
Copenhagen
Country [98] 0 0
Denmark
State/province [98] 0 0
Herlev
Country [99] 0 0
Denmark
State/province [99] 0 0
Odense
Country [100] 0 0
Denmark
State/province [100] 0 0
Silkeborg
Country [101] 0 0
Estonia
State/province [101] 0 0
Tallinn
Country [102] 0 0
Estonia
State/province [102] 0 0
Tartu
Country [103] 0 0
France
State/province [103] 0 0
AMIENS cedex 1
Country [104] 0 0
France
State/province [104] 0 0
Besancon
Country [105] 0 0
France
State/province [105] 0 0
Créteil
Country [106] 0 0
France
State/province [106] 0 0
Grenoble
Country [107] 0 0
France
State/province [107] 0 0
Marseille
Country [108] 0 0
France
State/province [108] 0 0
Nantes
Country [109] 0 0
France
State/province [109] 0 0
Neuilly-sur-Seine
Country [110] 0 0
France
State/province [110] 0 0
Nice
Country [111] 0 0
France
State/province [111] 0 0
Paris
Country [112] 0 0
France
State/province [112] 0 0
Pierre-Bénite
Country [113] 0 0
France
State/province [113] 0 0
Rennes
Country [114] 0 0
France
State/province [114] 0 0
Saint-Brieuc
Country [115] 0 0
France
State/province [115] 0 0
Saint-Etienne
Country [116] 0 0
France
State/province [116] 0 0
Toulouse
Country [117] 0 0
France
State/province [117] 0 0
Vandoeuvre les Nancy
Country [118] 0 0
Germany
State/province [118] 0 0
Berlin-Karlshorst
Country [119] 0 0
Germany
State/province [119] 0 0
Berlin
Country [120] 0 0
Germany
State/province [120] 0 0
Dachau
Country [121] 0 0
Germany
State/province [121] 0 0
Dresden
Country [122] 0 0
Germany
State/province [122] 0 0
Duisburg
Country [123] 0 0
Germany
State/province [123] 0 0
Erlangen
Country [124] 0 0
Germany
State/province [124] 0 0
Essen
Country [125] 0 0
Germany
State/province [125] 0 0
Frankfurt/Main
Country [126] 0 0
Germany
State/province [126] 0 0
Frankfurt
Country [127] 0 0
Germany
State/province [127] 0 0
Freiburg
Country [128] 0 0
Germany
State/province [128] 0 0
Fulda
Country [129] 0 0
Germany
State/province [129] 0 0
Haag
Country [130] 0 0
Germany
State/province [130] 0 0
Halle Saale
Country [131] 0 0
Germany
State/province [131] 0 0
Halle
Country [132] 0 0
Germany
State/province [132] 0 0
Hamburg
Country [133] 0 0
Germany
State/province [133] 0 0
Hannover
Country [134] 0 0
Germany
State/province [134] 0 0
Heidelberg
Country [135] 0 0
Germany
State/province [135] 0 0
Jena
Country [136] 0 0
Germany
State/province [136] 0 0
Jerichow
Country [137] 0 0
Germany
State/province [137] 0 0
Kassel
Country [138] 0 0
Germany
State/province [138] 0 0
Kiel
Country [139] 0 0
Germany
State/province [139] 0 0
Köln
Country [140] 0 0
Germany
State/province [140] 0 0
Leipzig
Country [141] 0 0
Germany
State/province [141] 0 0
Lueneburg
Country [142] 0 0
Germany
State/province [142] 0 0
Mannheim
Country [143] 0 0
Germany
State/province [143] 0 0
Minden
Country [144] 0 0
Germany
State/province [144] 0 0
Munich
Country [145] 0 0
Germany
State/province [145] 0 0
Munster
Country [146] 0 0
Germany
State/province [146] 0 0
Münster
Country [147] 0 0
Germany
State/province [147] 0 0
Nordhausen
Country [148] 0 0
Germany
State/province [148] 0 0
Nürtingen
Country [149] 0 0
Germany
State/province [149] 0 0
Regensburg
Country [150] 0 0
Germany
State/province [150] 0 0
Rostock
Country [151] 0 0
Germany
State/province [151] 0 0
Saarbrücken
Country [152] 0 0
Germany
State/province [152] 0 0
Tübingen
Country [153] 0 0
Germany
State/province [153] 0 0
Ulm
Country [154] 0 0
Germany
State/province [154] 0 0
Würzburg
Country [155] 0 0
Greece
State/province [155] 0 0
Athens
Country [156] 0 0
Greece
State/province [156] 0 0
Thessaloniki
Country [157] 0 0
Hungary
State/province [157] 0 0
Budapest
Country [158] 0 0
Hungary
State/province [158] 0 0
Gyongyos
Country [159] 0 0
Hungary
State/province [159] 0 0
Szeged
Country [160] 0 0
Hungary
State/province [160] 0 0
Szombathely
Country [161] 0 0
India
State/province [161] 0 0
Ahmedabad
Country [162] 0 0
India
State/province [162] 0 0
Bengaluru
Country [163] 0 0
India
State/province [163] 0 0
Bhubaneswar
Country [164] 0 0
India
State/province [164] 0 0
Chennai
Country [165] 0 0
India
State/province [165] 0 0
Gurugram
Country [166] 0 0
India
State/province [166] 0 0
Hyderabad
Country [167] 0 0
India
State/province [167] 0 0
Mumbai
Country [168] 0 0
India
State/province [168] 0 0
New Delhi
Country [169] 0 0
India
State/province [169] 0 0
Secunderabad
Country [170] 0 0
India
State/province [170] 0 0
Surat
Country [171] 0 0
Israel
State/province [171] 0 0
Afula
Country [172] 0 0
Israel
State/province [172] 0 0
Haifa
Country [173] 0 0
Israel
State/province [173] 0 0
Jerusalem
Country [174] 0 0
Israel
State/province [174] 0 0
Petah Tikva
Country [175] 0 0
Israel
State/province [175] 0 0
Rehovot
Country [176] 0 0
Israel
State/province [176] 0 0
Tel Aviv
Country [177] 0 0
Israel
State/province [177] 0 0
Tel Hashomer
Country [178] 0 0
Israel
State/province [178] 0 0
Tzrifin
Country [179] 0 0
Italy
State/province [179] 0 0
Bari
Country [180] 0 0
Italy
State/province [180] 0 0
Catania
Country [181] 0 0
Italy
State/province [181] 0 0
Messina
Country [182] 0 0
Italy
State/province [182] 0 0
Milano
Country [183] 0 0
Italy
State/province [183] 0 0
Monopoli
Country [184] 0 0
Italy
State/province [184] 0 0
Monserrato
Country [185] 0 0
Italy
State/province [185] 0 0
Monza
Country [186] 0 0
Italy
State/province [186] 0 0
Negrar ( Ve)
Country [187] 0 0
Italy
State/province [187] 0 0
Palermo
Country [188] 0 0
Italy
State/province [188] 0 0
Roma
Country [189] 0 0
Italy
State/province [189] 0 0
Rozzano
Country [190] 0 0
Italy
State/province [190] 0 0
Torino
Country [191] 0 0
Japan
State/province [191] 0 0
Asahikawa
Country [192] 0 0
Japan
State/province [192] 0 0
Bunkyo Ku
Country [193] 0 0
Japan
State/province [193] 0 0
Chikushino
Country [194] 0 0
Japan
State/province [194] 0 0
Fukuoka-shi
Country [195] 0 0
Japan
State/province [195] 0 0
Hachioji
Country [196] 0 0
Japan
State/province [196] 0 0
Hamamatsu
Country [197] 0 0
Japan
State/province [197] 0 0
Hirosaki
Country [198] 0 0
Japan
State/province [198] 0 0
Hitachi
Country [199] 0 0
Japan
State/province [199] 0 0
Hukuoka
Country [200] 0 0
Japan
State/province [200] 0 0
Hyogo
Country [201] 0 0
Japan
State/province [201] 0 0
Kagoshima
Country [202] 0 0
Japan
State/province [202] 0 0
Kamakura
Country [203] 0 0
Japan
State/province [203] 0 0
Kanazawa
Country [204] 0 0
Japan
State/province [204] 0 0
Kashiwa
Country [205] 0 0
Japan
State/province [205] 0 0
Kawagoe
Country [206] 0 0
Japan
State/province [206] 0 0
Kitakyushu
Country [207] 0 0
Japan
State/province [207] 0 0
Kobe
Country [208] 0 0
Japan
State/province [208] 0 0
Kumamoto
Country [209] 0 0
Japan
State/province [209] 0 0
Kurume
Country [210] 0 0
Japan
State/province [210] 0 0
Kyoto
Country [211] 0 0
Japan
State/province [211] 0 0
Mitaka
Country [212] 0 0
Japan
State/province [212] 0 0
Morioka
Country [213] 0 0
Japan
State/province [213] 0 0
Nagaoka
Country [214] 0 0
Japan
State/province [214] 0 0
Nagasaki
Country [215] 0 0
Japan
State/province [215] 0 0
Nagoya
Country [216] 0 0
Japan
State/province [216] 0 0
Niigata
Country [217] 0 0
Japan
State/province [217] 0 0
Okayama-shi
Country [218] 0 0
Japan
State/province [218] 0 0
Osaka
Country [219] 0 0
Japan
State/province [219] 0 0
Otsu
Country [220] 0 0
Japan
State/province [220] 0 0
Saga-shi
Country [221] 0 0
Japan
State/province [221] 0 0
Saitama
Country [222] 0 0
Japan
State/province [222] 0 0
Sakura
Country [223] 0 0
Japan
State/province [223] 0 0
Sapporo
Country [224] 0 0
Japan
State/province [224] 0 0
Sendai
Country [225] 0 0
Japan
State/province [225] 0 0
Shimotsuga-gun
Country [226] 0 0
Japan
State/province [226] 0 0
Shimotsuke
Country [227] 0 0
Japan
State/province [227] 0 0
Shinjuku-Ku
Country [228] 0 0
Japan
State/province [228] 0 0
Sumida ku
Country [229] 0 0
Japan
State/province [229] 0 0
Takamatsu
Country [230] 0 0
Japan
State/province [230] 0 0
Tokyo
Country [231] 0 0
Japan
State/province [231] 0 0
Toyama
Country [232] 0 0
Japan
State/province [232] 0 0
Toyota
Country [233] 0 0
Japan
State/province [233] 0 0
Tsu
Country [234] 0 0
Japan
State/province [234] 0 0
Yokohama
Country [235] 0 0
Jordan
State/province [235] 0 0
Amman
Country [236] 0 0
Jordan
State/province [236] 0 0
Irbid
Country [237] 0 0
Korea, Republic of
State/province [237] 0 0
Busan
Country [238] 0 0
Korea, Republic of
State/province [238] 0 0
Daegu
Country [239] 0 0
Korea, Republic of
State/province [239] 0 0
Goyang-si
Country [240] 0 0
Korea, Republic of
State/province [240] 0 0
Gwangju
Country [241] 0 0
Korea, Republic of
State/province [241] 0 0
Hwaseong-si
Country [242] 0 0
Korea, Republic of
State/province [242] 0 0
Seongnam-si
Country [243] 0 0
Korea, Republic of
State/province [243] 0 0
Seoul
Country [244] 0 0
Korea, Republic of
State/province [244] 0 0
Suwon-si
Country [245] 0 0
Korea, Republic of
State/province [245] 0 0
Suwon
Country [246] 0 0
Malaysia
State/province [246] 0 0
Alor Setar
Country [247] 0 0
Malaysia
State/province [247] 0 0
Ampang
Country [248] 0 0
Malaysia
State/province [248] 0 0
George Town
Country [249] 0 0
Malaysia
State/province [249] 0 0
Kuala Lumpur
Country [250] 0 0
Netherlands
State/province [250] 0 0
Amsterdam
Country [251] 0 0
Netherlands
State/province [251] 0 0
Dordrecht
Country [252] 0 0
Netherlands
State/province [252] 0 0
Leiden
Country [253] 0 0
Netherlands
State/province [253] 0 0
Maastricht
Country [254] 0 0
Netherlands
State/province [254] 0 0
Rotterdam
Country [255] 0 0
Netherlands
State/province [255] 0 0
Utrecht
Country [256] 0 0
New Zealand
State/province [256] 0 0
Dunedin
Country [257] 0 0
New Zealand
State/province [257] 0 0
Lower Hutt
Country [258] 0 0
New Zealand
State/province [258] 0 0
Wellington
Country [259] 0 0
Norway
State/province [259] 0 0
Alesund
Country [260] 0 0
Norway
State/province [260] 0 0
Gjettum
Country [261] 0 0
Norway
State/province [261] 0 0
Lørenskog
Country [262] 0 0
Norway
State/province [262] 0 0
Oslo
Country [263] 0 0
Norway
State/province [263] 0 0
Tromso
Country [264] 0 0
Poland
State/province [264] 0 0
Bydgoszcz
Country [265] 0 0
Poland
State/province [265] 0 0
Krakow
Country [266] 0 0
Poland
State/province [266] 0 0
Lodz
Country [267] 0 0
Poland
State/province [267] 0 0
Lublin
Country [268] 0 0
Poland
State/province [268] 0 0
Olsztyn
Country [269] 0 0
Poland
State/province [269] 0 0
Poznan
Country [270] 0 0
Poland
State/province [270] 0 0
Rzeszow
Country [271] 0 0
Poland
State/province [271] 0 0
Sopot
Country [272] 0 0
Poland
State/province [272] 0 0
Szczecin
Country [273] 0 0
Poland
State/province [273] 0 0
Torun
Country [274] 0 0
Poland
State/province [274] 0 0
Warszawa
Country [275] 0 0
Poland
State/province [275] 0 0
Wloclawek
Country [276] 0 0
Poland
State/province [276] 0 0
Wroclaw
Country [277] 0 0
Poland
State/province [277] 0 0
Zamosc
Country [278] 0 0
Portugal
State/province [278] 0 0
Lisboa
Country [279] 0 0
Portugal
State/province [279] 0 0
Portimao
Country [280] 0 0
Portugal
State/province [280] 0 0
Porto
Country [281] 0 0
Portugal
State/province [281] 0 0
Santa Maria da Feira
Country [282] 0 0
Singapore
State/province [282] 0 0
Singapore
Country [283] 0 0
Slovenia
State/province [283] 0 0
Celje
Country [284] 0 0
Slovenia
State/province [284] 0 0
Ljubljana
Country [285] 0 0
South Africa
State/province [285] 0 0
Benoni
Country [286] 0 0
South Africa
State/province [286] 0 0
Cape Town
Country [287] 0 0
South Africa
State/province [287] 0 0
Durban
Country [288] 0 0
Spain
State/province [288] 0 0
Madrid
Country [289] 0 0
Spain
State/province [289] 0 0
Pamplona
Country [290] 0 0
Spain
State/province [290] 0 0
Pontevedra
Country [291] 0 0
Spain
State/province [291] 0 0
Sabadell
Country [292] 0 0
Spain
State/province [292] 0 0
Santander
Country [293] 0 0
Spain
State/province [293] 0 0
Torrejón de Ardoz
Country [294] 0 0
Sweden
State/province [294] 0 0
Orebro
Country [295] 0 0
Sweden
State/province [295] 0 0
Solna
Country [296] 0 0
Sweden
State/province [296] 0 0
Stockholm
Country [297] 0 0
Switzerland
State/province [297] 0 0
Basel
Country [298] 0 0
Switzerland
State/province [298] 0 0
Bern
Country [299] 0 0
Switzerland
State/province [299] 0 0
St. Gallen
Country [300] 0 0
Switzerland
State/province [300] 0 0
Zuerich
Country [301] 0 0
Taiwan
State/province [301] 0 0
Changhua
Country [302] 0 0
Taiwan
State/province [302] 0 0
Taichung
Country [303] 0 0
Taiwan
State/province [303] 0 0
Tainan
Country [304] 0 0
Taiwan
State/province [304] 0 0
Taipei
Country [305] 0 0
United Kingdom
State/province [305] 0 0
Belfast
Country [306] 0 0
United Kingdom
State/province [306] 0 0
Birmingham
Country [307] 0 0
United Kingdom
State/province [307] 0 0
Cambridge
Country [308] 0 0
United Kingdom
State/province [308] 0 0
Glasgow
Country [309] 0 0
United Kingdom
State/province [309] 0 0
High Wycombe
Country [310] 0 0
United Kingdom
State/province [310] 0 0
London
Country [311] 0 0
United Kingdom
State/province [311] 0 0
Oxford
Country [312] 0 0
United Kingdom
State/province [312] 0 0
Wolverhampton.

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Janssen Research & Development, LLC
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Trial website
https://clinicaltrials.gov/study/NCT05242471
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Janssen Research & Development, LLC Clinical Trial
Address 0 0
Janssen Research & Development, LLC
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Study Contact
Address 0 0
Country 0 0
Phone 0 0
844-434-4210
Fax 0 0
Email 0 0
[email protected]
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT05242471